NovaTarg, Inc.
3Patents
3Active
3Granted
54Portfolio score
Filing activity: Dec 7, 2017 → Oct 26, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11261157B2 | Fused bicyclic alkylene linked imidodicarbonimidic diamides, methods for synthesis, and uses in therapy | Emerging Cross-Sectional Technologies | 2 | Active |
| US11834411B2 | Fused bicyclic alkylene linked imidodicarbonimidic diamides, methods for synthesis, and uses in therapy | Emerging Cross-Sectional Technologies | 1 | Active |
| US12371404B2 | Fused bicyclic alkylene linked imidodicarbonimidic diamides, methods for synthesis, and uses in therapy | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.